Epidemiology and Genomics Research
APRIL 2017

Follow us on Twitter
APRIL 2017 Features
Contact Us
 Opportunity Announcements
PAR-16-348 (R03)
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource 
Application Due Dates: Standard Dates Apply
Expiration Date: September 8, 2019

PA-17-243 (R21)
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes
Application Due Dates:  Standard Dates Apply
Expiration Date: May 8, 2020

PAR-17-244 (Collaborative R01)
PAR-17-245 (R01)
Research Projects to Enhance Applicability of Mammalian Models for Translational Research
Application Due Dates: Standard Dates Apply
Expiration Date: May 20, 2020

RFA-CA-017 (R01)
RFA-CA-018 (R21)  
Research Answers to NCI's Provocative Questions 
Application Due Dates: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018
Expiration Date: October 31, 2018

RFA-CA-17-019  (R01)
RFA-CA-17-020  (U01)
RFA-CA-17-021  (P01)
RFA-CA-17-022  (P50)
Revision Applications to NCI-Supported Awards to Include Research on the NCI's Provocative Questions
Applications Due: June 28, 2017; October 30, 2017; June 28, 2018; October 30, 2018 
Expiration Date: October 31, 2018 

PolicyGrants Policy Announcements
Update and Clarification: NIH Continuous Submission Policy
New Policy Eliminates Most Appendix Material for NIH/AHRQ/NIOSH Applications Submitted for Due Dates On or After January 25, 2017
RFIRequests for Information
NIH Prevention Research Expertise Survey
The NIH Office of Disease Prevention (ODP) is looking for experts in various fields of prevention research to potentially serve as reviewers of NIH research grant applications. This survey, open indefinitely, collects data on scientists' methodological and content expertise, which will be used to support a web-based electronic directory that the NIH Scientific Review Officers can use to identify researchers with expertise in specific prevention science methods and content areas to serve on NIH study sections.
JobsJob Opportunities
EventsUpcoming Events

May 3, 2017
Bethesda, MD

May 3-5, 2017
New Orleans, LA

May 4-5, 2017
Memphis, TN

Webinar: Utilization, Adherence, and Health Care Delivery of Oral Anticancer Agents
May 9, 2017

May 16-17, 2017
Bethesda, MD

May 31-June 1, 2017
Rockville, MD

Understudied Populations Webinar: Cancer Health Disparities in Outcomes and Survivorship Among Adolescents
June 6, 2017

June 21, 2017

International Conference on Ambulatory Monitoring of Physical Activity and Movement
June 21-23, 2017
Bethesda, MD
Note: Registration deadline is May 21, 2017

Infectious Agents and Cancer Epidemiology Research Webinar: Epidemiology and Perinatal Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Sub-Saharan Africa
June 29, 2017

SAVE THE DATE: Understanding the Role of Muscle and Body Composition in Studies of Cancer Risk and Prognosis in Cancer Survivors
September 25-26, 2017
Rockville, MD
KeyReportsKey Reports
Annual Report to the Nation on the Status of Cancer, 1975-2014
BlogsBlog Posts
Making Greater Progress Against Cancer - Not Just a Hope but a Reality
Dr. Douglas R. Lowy
Cancer Currents Blog

Colorectal Cancer Incidence Rising in Young Adults
Drs. Philip Rosenberg and William Anderson
Cancer Currents Blog

Random Mutations Play Major Role in Cancer
Dr. Francis Collins
NIH Director's Blog

AboutAbout EGRP
The Epidemiology and Genomics Research Program (EGRP) in the Division of Cancer Control and Population Sciences (DCCPS) funds research in human populations to understand the causes of cancer and related outcomes.

The Program fosters interdisciplinary collaborations, as well as the development and use of resources and technologies to advance cancer research and translation of this research, which serve as the basis for clinical and public health interventions.
ContactContact Us
email: nciepimatters@mail.nih.gov
website: epi.grants.cancer.gov
twitter: twitter.com/NCIEpi
New Funding Opportunities & Research Resources for Cancer Epidemiology Studies
Data from cancer epidemiology studies help researchers better understand the complex etiology of cancer and provide fundamental insights into key environmental, lifestyle, clinical, and genetic determinants of cancer and its outcomes. 

The National Cancer Institute's Epidemiology and Genomics Research Program (EGRP)  supports Funding Opportunity Announcements (FOAs) for hypothesis-based scientific research through investigator-initiated Research Project Grant applications  ( R01s and Research Program Project Applications ( P01s )

There is also a dedicated FOA ( PAR-17-233 ), which was published in March 2017, that supports the basic maintenance of infrastructure in existing cohorts. For more information about this PAR, see EGRP's webpage with answers to Frequently Asked Questions.  

Several administrative supplement opportunities were also published in March 2017 in the NIH Guide for Grants and Contracts to promote data sharing, collection of residential histories, and studies of rare cancers in existing cancer epidemiology studies. Applications for each of the following supplements are due by June 1, 2017:

  • PA-17-224, Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies
  • PA-17-222, Research Supplements for Validating the Use of Automated Sources of Residential Histories in Cancer Epidemiology Cohorts
  • PA-17-223, Research Supplement Opportunity to Support Population-Based Research Studies of Rare Cancers
For additional FOAs relevant to epidemiologic research, see EGRP's funding opportunities webpage

EGRP also supports a wide variety of research resources, including those that promote data sharing and collaboration among epidemiologists and others in the research community. 

The newest of EGRP's research resources is the  Cancer Epidemiology Data Repository (CEDR), a centralized, controlled-access database where investigators can deposit individual-level de-identified observational cancer datasets. CEDR is modeled after similar NIH-supported data repositories (e.g., BioLINCC), which have enabled collaboration and accelerated scientific discovery.

Investigators will be able to deposit non-genomic data from observational cancer epidemiology studies into CEDR, which could be linked to genomic data in NIH's database of Genotypes and Phenotypes ( dbGaP). CEDR will be ready to accept data by Fall 2017.

Released data will not contain information that readily allows identification of an individual participant, consistent with NCI policies. Data will be shared in concordance with specific data use agreements for each study. Researchers requesting repository data will provide regular progress reports and notify EGRP of manuscripts published with data accessed from CEDR, with the appropriate data citation. 
In August 2016, NIH published a  Notice in the Guide for Grants and Contracts outlining changes that eliminate most Appendix material from NIH grant applications submitted on or after January 25, 2017, including A1 resubmissions. 

All information required for a grant application to be reviewed must be found within the pages of the Specific Aims and Research Strategy sections of the application. Only the items listed in NOT-OD-16-129, plus any additional items specifically listed in the individual Funding Opportunity Announcement (FOA) as required or optional are allowed in the Appendix.

Applications that contain appendix materials not specifically referenced in NOT-OD-16-129, or the specific FOA that the application is responding to, will be withdrawn and not reviewed. The instructions in NOT-OD-16-129 supersede other general NIH instructions for Appendix materials.

Allowed Appendix materials:
  • Blank informed consent forms
  • Blank surveys, questionnaires, and data collection instruments (see examples)
  • If any additional appendix materials are required by an FOA, they will be specified in the Review Criteria section of the FOA

Materials NOT allowed in the Appendix: 

  • Letters of Support (should be attached to the PHS 398 Research Plan Form in the Other Research Plan section)
  • Publications, manuscripts, or abstracts
  • Instructions for the administration of a survey or questionnaire (these are part of the experimental methods and should be addressed within the Research Strategy section)
  • Lists or tables of data to be collected
  • See more examples

Many items not allowed in the Appendix are specified as required in other parts of the application or allowed within the page limits of the Research Strategy section of an FOA.

NIH cannot change or modify applications after submission. The application must be submitted again, with a compliant Appendix, for any subsequent due date in order to be sent forward to review.

NIH has created a web page with answers to some frequently asked questions about this policy change. Additional questions should be directed to the Division of Receipt and Referral at NIH's Center for Scientific Review at csrdrr@mail.nih.gov.

Celebrating National Poetry Month with Epidemiology Haiku
In acknowledgement of April as National Poetry Month, EGRP has decided to elicit a different area of our scientists' creativity by holding a haiku contest!

A haiku is a Japanese form of poetry consisting of three unrhymed lines. The first and third lines have five syllables, and the second line has seven. EGRP staff submitted a total of 15 poems on topics related to EGRP's research and mission; here we present the winning submissions for our subscribers to enjoy.

Our poets in EGRP have captured the spirit of our mission to understand the underlying causes of cancer and cancer outcomes with eloquence, style, humor, and fun. Thanks to all who participated and congratulations to our winners!
Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute | 9609 Medical Center Drive | 4 East, MSC 9763 | Bethesda | MD 20892